SION
Sionna Therapeutics·NASDAQ
--
--(--)
--
--(--)
7.37 / 10
Outperform
Analyst coverage is strong and uniformly bullish (100% Strong Buy), with a historical 100% win rate for recent predictions. Fund-flow analysis reveals consistent inflows across block, small, medium, large, and extra-large trades, supporting positive sentiment. Together, analyst conviction and capital accumulation bolster the stock's near-term outlook despite neutral technicals.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-14
InstitutionBTIG
Times predicted3
Historical Win Rate100.0%
What is the analyst consensus for SION?
- SION holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 7.37/10 (Outperform).
